Bitte aktiviere Javascript und schalte etwaige Werbeblocker ab

Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: United Internet gets off to successful start in fiscal year 2024 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png

EQS-News: United Internet gets off to successful start in fiscal year 2024

EQS-News: United Internet gets off to successful start in fiscal year 2024

0

EQS-News: Bechtle Affirms Forecast for the Year As a Whole: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png

EQS-News: Bechtle Affirms Forecast for the Year As a Whole

EQS-News: Bechtle Affirms Forecast for the Year As a Whole

0

EQS-Adhoc: VARTA AG: Michael Ostermann appointed new CEO of VARTA AG

EQS-Adhoc: VARTA AG: Michael Ostermann appointed new CEO of VARTA AG

0

EQS-News: As expected, Siltronic's Q1 2024 earnings continue to be impacted by weak demand due to elevated customer inventories: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png

EQS-News: As expected, Siltronic's Q1 2024 earnings continue to be impacted by weak demand due to elevated customer inventories

EQS-News: As expected, Siltronic's Q1 2024 earnings continue to be impacted by weak demand due to elevated customer inventories

0

EQS-News: Bayer and Evotec collaborate to advance precision cardiology: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Bayer and Evotec collaborate to advance precision cardiology

EQS-News: Bayer and Evotec collaborate to advance precision cardiology

0

EQS-News: Nemetschek Group: Successful start to the year in Q1 2024 with double-digit operational revenue growth at a continued high profitability level: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png

EQS-News: Nemetschek Group: Successful start to the year in Q1 2024 with double-digit operational revenue growth at a continued high profitability level

EQS-News: Nemetschek Group: Successful start to the year in Q1 2024 with double-digit operational revenue growth at a continued high profitability level

0

EQS-News: MorphoSys AG Reports First Quarter 2024 Financial Results

EQS-News: MorphoSys AG Reports First Quarter 2024 Financial Results

0

EQS-Adhoc: Siltronic adjusts guidance for the financial year 2024 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png

EQS-Adhoc: Siltronic adjusts guidance for the financial year 2024

EQS-Adhoc: Siltronic adjusts guidance for the financial year 2024

0

EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting

EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting

0

EQS-News: Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth

EQS-News: Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth

0

EQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

EQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

0

EQS-Adhoc: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-Adhoc: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

EQS-Adhoc: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

0

EQS-News: Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments

EQS-News: Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments

0

EQS-News: Evotec SE to announce results for fiscal year 2023 on 24 April 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec SE to announce results for fiscal year 2023 on 24 April 2024

EQS-News: Evotec SE to announce results for fiscal year 2023 on 24 April 2024

0

EQS-News: Evotec welcomes Aurélie Dalbiez as Chief People Officer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec welcomes Aurélie Dalbiez as Chief People Officer

EQS-News: Evotec welcomes Aurélie Dalbiez as Chief People Officer

0

EQS-News: Nagarro releases audited results for 2023 - annual revenue grew 9.4% in constant currency: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png

EQS-News: Nagarro releases audited results for 2023 - annual revenue grew 9.4% in constant currency

EQS-News: Nagarro releases audited results for 2023 - annual revenue grew 9.4% in constant currency

0

EQS-Adhoc: Delisting of Telefónica Deutschland shares from Frankfurt Stock Exchange effective as of end of 18. April 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png

EQS-Adhoc: Delisting of Telefónica Deutschland shares from Frankfurt Stock Exchange effective as of end of 18. April 2024

EQS-Adhoc: Delisting of Telefónica Deutschland shares from Frankfurt Stock Exchange effective as of end of 18. April 2024

0

EQS-Adhoc: VARTA AG: VARTA AG updates restructuring concept

EQS-Adhoc: VARTA AG: VARTA AG updates restructuring concept

0

EQS-News: MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis

EQS-News: MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis

0

EQS-News: CANCOM SE: CANCOM publishes Annual Report 2023 and forecasts significant growth: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png

EQS-News: CANCOM SE: CANCOM publishes Annual Report 2023 and forecasts significant growth

EQS-News: CANCOM SE: CANCOM publishes Annual Report 2023 and forecasts significant growth

0

EQS-News: Telefónica Deutschland's Management Board and Supervisory Board jointly recommend acceptance of the public delisting acquisition offer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png

EQS-News: Telefónica Deutschland's Management Board and Supervisory Board jointly recommend acceptance of the public delisting acquisition offer

EQS-News: Telefónica Deutschland's Management Board and Supervisory Board jointly recommend acceptance of the public delisting acquisition offer

0

EQS-News: freenet confirms the preliminary results for the 2023 financial year, the proposed dividend of EUR 1.77 and the 2024 guidance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png

EQS-News: freenet confirms the preliminary results for the 2023 financial year, the proposed dividend of EUR 1.77 and the 2024 guidance

EQS-News: freenet confirms the preliminary results for the 2023 financial year, the proposed dividend of EUR 1.77 and the 2024 guidance

0

EQS-News: Siltronic ends wafer production for 'small diameters': http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png

EQS-News: Siltronic ends wafer production for 'small diameters'

EQS-News: Siltronic ends wafer production for 'small diameters'

0

EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act

EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act

0

EQS-News: 1&1 with successful fiscal year 2023 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png

EQS-News: 1&1 with successful fiscal year 2023

EQS-News: 1&1 with successful fiscal year 2023

0